معرفی
James Farrell, MD, is a Professor of Medicine and Surgery at Yale School of Medicine, and Director of the Yale Center for Pancreatic Diseases. He specializes in gastrointestinal endoscopy, pancreatic diseases, and interventional endoscopy. His research focuses on pancreatic cancer early detection, pancreatic cyst management, and personalized therapy. Dr. Farrell leads the Smilow Cancer Center High Risk Pancreas Cancer Early Detection Clinic and chairs the Yale Digestive Health Pancreatic Cyst Program.
Education:
- MBChB, University College Dublin, 1992
- Internal Medicine Residency, St Vincent’s University Hospital, 1992
- Advanced Therapeutic Endoscopy Fellowship, Massachusetts General Hospital & Brigham and Women’s Hospital, 2001
Research Interests: Dr. Farrell’s work centers on pancreatic cancer biomarkers, endoscopic techniques for diagnosis, and clinical trials for high-risk populations. He leads international consortia like the PRECEDE study and chairs pancreatic surveillance programs. His lab maintains a pancreatic cyst fluid biobank with over 400 specimens.
Key Contributions:
- Validating hENT1 as a biomarker for gemcitabine responsiveness
- Developing surveillance protocols for high-risk pancreatic cancer patients
- Advocating for disparities research in pancreatic screening
Grants & Labs: Active in NIH-funded studies and collaborates with teams at Smilow Cancer Center and the Yale Interventional Endoscopy Program. His lab focuses on translational research bridging endoscopy and molecular diagnostics.
Labs/Teams: Yale Pancreas Cancer Early Detection Clinic, Smilow Cancer Genetics & Prevention Program, and the Yale Center for Pancreatic Diseases.
